Amgen Announces Approval Of Aimovig (Erenumab) In Japan For The Suppression Of Onset Of Migraine Attacks In Adults Read more
AbCellera Continues Expansion and Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility for Therapeutic Antibodies in Canada Read more
European Commission Purchases Additional 150 Million Doses of Moderna’s COVID-19 Vaccine for Delivery in 2022 Read more
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform Read more
Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using World’s Fastest Supercomputer with Researchers of Research Center for Advanced Science and Technology, The University of Tokyo Read more
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of “ultra-long-acting” medicines for HIV Read more
Grace Science Receives U.S. FDA Orphan Drug Designation for GS-100, an AAV9 Gene Therapy for NGLY1 Deficiency Read more
Hear from Industry Experts at the 2nd annual Wearable Injectors and Connected Devices Conference 2021 Read more
Engage with leading experts on wearable devices for remote diagnostics and patient monitoring Read more